Cargando…

Validation of multiplex PCR sequencing assay of SIV

BACKGROUND: The generation of accurate and reproducible viral sequence data is necessary to understand the diversity present in populations of RNA viruses isolated from clinical samples. While various sequencing methods are available, they often require high quality templates and high viral titer to...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriarty, Ryan V., Fesser, Nicolas, Sutton, Matthew S., Venturi, Vanessa, Davenport, Miles P., Schlub, Timothy, O’Connor, Shelby L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810186/
https://www.ncbi.nlm.nih.gov/pubmed/33451356
http://dx.doi.org/10.1186/s12985-020-01473-0
_version_ 1783637268465975296
author Moriarty, Ryan V.
Fesser, Nicolas
Sutton, Matthew S.
Venturi, Vanessa
Davenport, Miles P.
Schlub, Timothy
O’Connor, Shelby L.
author_facet Moriarty, Ryan V.
Fesser, Nicolas
Sutton, Matthew S.
Venturi, Vanessa
Davenport, Miles P.
Schlub, Timothy
O’Connor, Shelby L.
author_sort Moriarty, Ryan V.
collection PubMed
description BACKGROUND: The generation of accurate and reproducible viral sequence data is necessary to understand the diversity present in populations of RNA viruses isolated from clinical samples. While various sequencing methods are available, they often require high quality templates and high viral titer to ensure reliable data. METHODS: We modified a multiplex PCR and sequencing approach to characterize populations of simian immunodeficiency virus (SIV) isolated from nonhuman primates. We chose this approach with the aim of reducing the number of required input templates while maintaining fidelity and sensitivity. We conducted replicate sequencing experiments using different numbers of quantified viral RNA (vRNA) or viral cDNA as input material. We performed assays with clonal SIVmac239 to detect false positives, and we mixed SIVmac239 and a variant with 24 point mutations (SIVmac239-24X) to measure variant detection sensitivity. RESULTS: We found that utilizing a starting material of quantified viral cDNA templates had a lower rate of false positives and increased reproducibility when compared to that of quantified vRNA templates. This study identifies the importance of rigorously validating deep sequencing methods and including replicate samples when using a new method to characterize low frequency variants in a population with a small number of templates. CONCLUSIONS: Because the need to generate reproducible and accurate sequencing data from diverse viruses from low titer samples, we modified a multiplex PCR and sequencing approach to characterize SIV from populations from non-human primates. We found that increasing starting template numbers increased the reproducibility and decreased the number of false positives identified, and this was further seen when cDNA was used as a starting material. Ultimately, we highlight the importance of vigorously validating methods to prevent overinterpretation of low frequency variants in a sample.
format Online
Article
Text
id pubmed-7810186
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78101862021-01-18 Validation of multiplex PCR sequencing assay of SIV Moriarty, Ryan V. Fesser, Nicolas Sutton, Matthew S. Venturi, Vanessa Davenport, Miles P. Schlub, Timothy O’Connor, Shelby L. Virol J Research BACKGROUND: The generation of accurate and reproducible viral sequence data is necessary to understand the diversity present in populations of RNA viruses isolated from clinical samples. While various sequencing methods are available, they often require high quality templates and high viral titer to ensure reliable data. METHODS: We modified a multiplex PCR and sequencing approach to characterize populations of simian immunodeficiency virus (SIV) isolated from nonhuman primates. We chose this approach with the aim of reducing the number of required input templates while maintaining fidelity and sensitivity. We conducted replicate sequencing experiments using different numbers of quantified viral RNA (vRNA) or viral cDNA as input material. We performed assays with clonal SIVmac239 to detect false positives, and we mixed SIVmac239 and a variant with 24 point mutations (SIVmac239-24X) to measure variant detection sensitivity. RESULTS: We found that utilizing a starting material of quantified viral cDNA templates had a lower rate of false positives and increased reproducibility when compared to that of quantified vRNA templates. This study identifies the importance of rigorously validating deep sequencing methods and including replicate samples when using a new method to characterize low frequency variants in a population with a small number of templates. CONCLUSIONS: Because the need to generate reproducible and accurate sequencing data from diverse viruses from low titer samples, we modified a multiplex PCR and sequencing approach to characterize SIV from populations from non-human primates. We found that increasing starting template numbers increased the reproducibility and decreased the number of false positives identified, and this was further seen when cDNA was used as a starting material. Ultimately, we highlight the importance of vigorously validating methods to prevent overinterpretation of low frequency variants in a sample. BioMed Central 2021-01-15 /pmc/articles/PMC7810186/ /pubmed/33451356 http://dx.doi.org/10.1186/s12985-020-01473-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Moriarty, Ryan V.
Fesser, Nicolas
Sutton, Matthew S.
Venturi, Vanessa
Davenport, Miles P.
Schlub, Timothy
O’Connor, Shelby L.
Validation of multiplex PCR sequencing assay of SIV
title Validation of multiplex PCR sequencing assay of SIV
title_full Validation of multiplex PCR sequencing assay of SIV
title_fullStr Validation of multiplex PCR sequencing assay of SIV
title_full_unstemmed Validation of multiplex PCR sequencing assay of SIV
title_short Validation of multiplex PCR sequencing assay of SIV
title_sort validation of multiplex pcr sequencing assay of siv
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810186/
https://www.ncbi.nlm.nih.gov/pubmed/33451356
http://dx.doi.org/10.1186/s12985-020-01473-0
work_keys_str_mv AT moriartyryanv validationofmultiplexpcrsequencingassayofsiv
AT fessernicolas validationofmultiplexpcrsequencingassayofsiv
AT suttonmatthews validationofmultiplexpcrsequencingassayofsiv
AT venturivanessa validationofmultiplexpcrsequencingassayofsiv
AT davenportmilesp validationofmultiplexpcrsequencingassayofsiv
AT schlubtimothy validationofmultiplexpcrsequencingassayofsiv
AT oconnorshelbyl validationofmultiplexpcrsequencingassayofsiv